161 related articles for article (PubMed ID: 35603896)
1. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
[TBL] [Abstract][Full Text] [Related]
2. Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis.
Yin Y; Liu Y; Xu M; Zhang X; Li C
Neurol Sci; 2021 Oct; 42(10):4085-4094. PubMed ID: 34346015
[TBL] [Abstract][Full Text] [Related]
3. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.
Dos Santos EUD; da Silva IIFG; Asano AGC; Asano NMJ; De Mascena Diniz Maia M; de Souza PRE
Mol Biol Rep; 2020 Nov; 47(11):8997-9004. PubMed ID: 33151475
[TBL] [Abstract][Full Text] [Related]
5. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
Sampaio TF; Dos Santos EUD; de Lima GDC; Dos Anjos RSG; da Silva RC; Asano AGC; Asano NMJ; Crovella S; de Souza PRE
J Clin Pharmacol; 2018 Jul; 58(7):920-926. PubMed ID: 29578580
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease.
Zhao C; Wang Y; Zhang B; Yue Y; Zhang J
Sci Rep; 2020 Jun; 10(1):9521. PubMed ID: 32533012
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.
Soraya GV; Ulhaq ZS; Shodry S; A'raaf Sirojan Kusuma M; Herawangsa S; Sativa MO; Gustaf A; Faridwazdi DAN; Florentia SW; Raisa N; Bintang AK; Akbar M
Neurol Sci; 2022 Jun; 43(6):3649-3670. PubMed ID: 35079903
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia.
Ivanova SA; Alifirova VM; Pozhidaev IV; Freidin MB; Zhukova IA; Osmanova DZ; Zhukova NG; Mironova YA; Tiguntsev VV; Fedorenko OY; Bokhan NA; Wilffert B; Loonen AJM
J Pharm Pharm Sci; 2018; 21(1):340-346. PubMed ID: 30075828
[TBL] [Abstract][Full Text] [Related]
9. COMT gene and risk for Parkinson's disease: a systematic review and meta-analysis.
Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Agúndez JA
Pharmacogenet Genomics; 2014 Jul; 24(7):331-9. PubMed ID: 24819480
[TBL] [Abstract][Full Text] [Related]
10. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
11. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
12. UNRAVELING THE CLINICO-GENETIC ASSOCIATION OF CATECHOL-O-METHYLTRANSFERASE-RS4680 G>A GENE POLYMORPHISM IN WOMEN WITH FIBROMYALGIA SYNDROME.
Parvez S; Fatima G; Mahdi F; Fedacko J; Hadi NR
Wiad Lek; 2022; 75(10):2439-2444. PubMed ID: 36472276
[TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
de Lau LM; Verbaan D; Marinus J; Heutink P; van Hilten JJ
Mov Disord; 2012 Jan; 27(1):132-5. PubMed ID: 22083803
[TBL] [Abstract][Full Text] [Related]
14. Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease.
Cheshire P; Bertram K; Ling H; O'Sullivan SS; Halliday G; McLean C; Bras J; Foltynie T; Storey E; Williams DR
Neurodegener Dis; 2014; 13(1):24-8. PubMed ID: 24008922
[TBL] [Abstract][Full Text] [Related]
15. Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.
Chuan L; Gao J; Lei Y; Wang R; Lu L; Zhang X
Neurol Sci; 2015 Jan; 36(1):109-15. PubMed ID: 25060648
[TBL] [Abstract][Full Text] [Related]
16. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
17. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
18. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
19. Potential Impact of
Mir R; Bhat M; Javid J; Jha C; Saxena A; Banu S
J Cardiovasc Dev Dis; 2018 Jul; 5(3):. PubMed ID: 30011860
[No Abstract] [Full Text] [Related]
20. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
Kumar P; Rai V
Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
